These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 6421343)
1. Platelet-collagen interactions: increase in rate of adhesion of fixed washed platelets by factor VIII-related antigen. Aihara M; Cooper HA; Wagner RH Blood; 1984 Mar; 63(3):495-501. PubMed ID: 6421343 [TBL] [Abstract][Full Text] [Related]
2. Effect of fibronectin and von Willebrand factor on the adhesion of human fixed washed platelets to collagen immobilized beads. Aihara M; Takami H; Sawada Y; Morimoto S; Kariya K; Kudo I; Ueno K; Kimura A; Yoshida Y Thromb Res; 1986 Dec; 44(5):661-72. PubMed ID: 3101223 [TBL] [Abstract][Full Text] [Related]
3. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time. Aihara M; Kimura A; Chiba Y; Yoshida Y Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084 [TBL] [Abstract][Full Text] [Related]
4. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor. d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373 [TBL] [Abstract][Full Text] [Related]
5. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060 [TBL] [Abstract][Full Text] [Related]
6. Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody. Fricke WA; Brinkhous KM; Garris JB; Roberts HR Blood; 1985 Sep; 66(3):562-9. PubMed ID: 3927998 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757 [TBL] [Abstract][Full Text] [Related]
8. Acquired von Willebrand disease associated with an inhibitor to factor VIII antigen and gastrointestinal telangiectasia. McGrath KM; Johnson CA; Stuart JJ Am J Med; 1979 Oct; 67(4):693-6. PubMed ID: 315164 [TBL] [Abstract][Full Text] [Related]
9. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944 [TBL] [Abstract][Full Text] [Related]
10. DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Sakariassen KS; Cattaneo M; vd Berg A; Ruggeri ZM; Mannucci PM; Sixma JJ Blood; 1984 Jul; 64(1):229-36. PubMed ID: 6428488 [TBL] [Abstract][Full Text] [Related]
11. Factor XIII is not involved in human platelet-collagen interaction. Aihara M; Sawada Y; Takami H; Kariya K; Kudo I; Kimura A; Yoshida Y Tohoku J Exp Med; 1989 Sep; 159(1):37-44. PubMed ID: 2815074 [TBL] [Abstract][Full Text] [Related]
12. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor. Allain JP; Cooper HA; Wagner RH; Brinkhous KM J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499 [TBL] [Abstract][Full Text] [Related]
13. Platelet-vessel-wall interactions: experiences with von Willebrand platelets. Barnhart MI; Wilkins RM; Lusher JM Ann N Y Acad Sci; 1981; 370():154-78. PubMed ID: 6791541 [TBL] [Abstract][Full Text] [Related]
14. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease. Johnstone IB; Crane S Can J Vet Res; 1987 Apr; 51(2):189-93. PubMed ID: 3111674 [TBL] [Abstract][Full Text] [Related]
15. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586). Hubbard AR; Rigsby P; Barrowcliffe TW Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497 [TBL] [Abstract][Full Text] [Related]
16. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442 [TBL] [Abstract][Full Text] [Related]
17. Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity. Goudemand J; Mazurier C; Marey A; Caron C; Coupez B; Mizon P; Goudemand M Br J Haematol; 1992 Feb; 80(2):214-21. PubMed ID: 1550779 [TBL] [Abstract][Full Text] [Related]
18. von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy. Favaloro EJ; Dean M; Grispo L; Exner T; Koutts J Am J Hematol; 1994 Mar; 45(3):205-11. PubMed ID: 8296790 [TBL] [Abstract][Full Text] [Related]
19. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. Weiss HJ; Rogers J; Brand H J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262 [TBL] [Abstract][Full Text] [Related]
20. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1. Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]